Reprogrammed mesenchymal stem cells derived from iPSCs promote bone repair in steroid-associated osteonecrosis of the femoral head

BACKGROUND: Cellular therapy based on mesenchymal stem cells (MSCs) is a promising novel therapeutic strategy for the osteonecrosis of the femoral head (ONFH), which is gradually becoming popular, particularly for early-stage ONFH. Nonetheless, the MSC-based therapy is challenging due to certain lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Meiling, Xi, Jiaoya, Cheng, Yaofeng, Sun, Denglong, Shu, Peng, Chi, Shuiqing, Tian, Shuo, Ye, Shunan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953570/
https://www.ncbi.nlm.nih.gov/pubmed/33712030
http://dx.doi.org/10.1186/s13287-021-02249-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953570/
https://www.ncbi.nlm.nih.gov/pubmed/33712030
http://dx.doi.org/10.1186/s13287-021-02249-1

Ejemplares similares